These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23344546)

  • 1. Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.
    Forthal DN; Landucci G; Chohan B; Richardson BA; McClelland RS; Jaoko W; Blish C; Overbaugh J
    J Acquir Immune Defic Syndr; 2013 May; 63(1):31-3. PubMed ID: 23344546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women.
    Ronen K; Dingens AS; Graham SM; Jaoko W; Mandaliya K; McClelland RS; Overbaugh J
    EBioMedicine; 2017 Apr; 18():216-224. PubMed ID: 28427948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.
    Wagner GA; Landais E; Caballero G; Phung P; Kosakovsky Pond SL; Poignard P; Richman DD; Little SJ; Smith DM
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
    Ssemwanga D; Doria-Rose NA; Redd AD; Shiakolas AR; Longosz AF; Nsubuga RN; Mayanja BN; Asiki G; Seeley J; Kamali A; Ransier A; Darko S; Walker MP; Bruno D; Martens C; Douek D; Porcella SF; Quinn TC; Mascola JR; Kaleebu P
    J Infect Dis; 2018 Apr; 217(10):1530-1534. PubMed ID: 29579256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection.
    Basu D; Kraft CS; Murphy MK; Campbell PJ; Yu T; Hraber PT; Irene C; Pinter A; Chomba E; Mulenga J; Kilembe W; Allen SA; Derdeyn CA; Hunter E
    Retrovirology; 2012 Sep; 9():76. PubMed ID: 22995123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.
    Serwanga J; Ssemwanga D; Muganga M; Nakiboneka R; Nakubulwa S; Kiwuwa-Muyingo S; Morris L; Redd AD; Quinn TC; Kaleebu P;
    Vaccine; 2018 Jan; 36(4):578-586. PubMed ID: 29274699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.
    Chaillon A; Wagner GA; Hepler NL; Little SJ; Kosakovsky Pond SL; Caballero G; Pacold ME; Phung P; Wrin T; Richman DD; Wertheim JO; Smith DM
    J Virol; 2013 Dec; 87(23):12737-44. PubMed ID: 24049166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.
    Cortez V; Odem-Davis K; McClelland RS; Jaoko W; Overbaugh J
    PLoS Pathog; 2012; 8(3):e1002611. PubMed ID: 22479183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV superinfection in women may boost immune response.
    Rose S
    Expert Rev Anti Infect Ther; 2012 May; 10(5):525. PubMed ID: 22702314
    [No Abstract]   [Full Text] [Related]  

  • 10. Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection.
    Basu D; Xiao P; Ende Z; Bere A; Britt WJ; Mulenga J; Kilembe W; Allen SA; Derdeyn CA; Hunter E
    Virology; 2014 Aug; 462-463():295-8. PubMed ID: 25004405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire.
    Williams KL; Wang B; Arenz D; Williams JA; Dingens AS; Cortez V; Simonich CA; Rainwater S; Lehman DA; Lee KK; Overbaugh J
    Cell Rep; 2018 Apr; 23(3):682-691. PubMed ID: 29669274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.
    Blish CA; Dogan OC; Derby NR; Nguyen MA; Chohan B; Richardson BA; Overbaugh J
    J Virol; 2008 Dec; 82(24):12094-103. PubMed ID: 18842728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.
    Smith DM; Strain MC; Frost SD; Pillai SK; Wong JK; Wrin T; Liu Y; Petropolous CJ; Daar ES; Little SJ; Richman DD
    Virology; 2006 Nov; 355(1):1-5. PubMed ID: 16962152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection.
    Cortez V; Wang B; Dingens A; Chen MM; Ronen K; Georgiev IS; McClelland RS; Overbaugh J
    PLoS Pathog; 2015 Jul; 11(7):e1004973. PubMed ID: 26158467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research. 'Superinfected' have more potent antibody response to HIV.
    AIDS Policy Law; 2012 May; 27(6):3. PubMed ID: 22655314
    [No Abstract]   [Full Text] [Related]  

  • 16. The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.
    Cornelissen M; Euler Z; van den Kerkhof TL; van Gils MJ; Boeser-Nunnink BD; Kootstra NA; Zorgdrager F; Schuitemaker H; Prins JM; Sanders RW; van der Kuyl AC
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1135-1142. PubMed ID: 26910384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with men.
    Redd AD; Helleberg M; Sievers M; Schmidt SD; Doria-Rose NA; Bruno D; Traeger S; Martens C; Fonager J; Kronborg G; Packman Z; Mascola JR; Porcella SF; Gerstoft J; Quinn TC
    Infect Dis (Lond); 2019 Jan; 51(1):56-61. PubMed ID: 30317905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth.
    Sheward DJ; Marais J; Bekker V; Murrell B; Eren K; Bhiman JN; Nonyane M; Garrett N; Woodman ZL; Abdool Karim Q; Abdool Karim SS; Morris L; Moore PL; Williamson C
    Cell Host Microbe; 2018 Oct; 24(4):593-599.e3. PubMed ID: 30269971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.
    Courtney CR; Mayr L; Nanfack AJ; Banin AN; Tuen M; Pan R; Jiang X; Kong XP; Kirkpatrick AR; Bruno D; Martens CA; Sykora L; Porcella SF; Redd AD; Quinn TC; Nyambi PN; Dürr R
    PLoS One; 2017; 12(3):e0173705. PubMed ID: 28288209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.